ESSM Position Statements

Each year, the European Society for Sexual Medicine (ESSM) publishes position statements on sexual medicine related issues that are of interest to its members and the public. You can view our recent position statements by following the links below. If you have questions or comments, please email to admin@essm.org.

Position Statements

March 2020

Radiofrequency-Based Devices for Female Genito-Urinary Indications

Radiofrequency (RF)-based treatment has been introduced as an esthetic alternative treatment for various medical indications without the scientific backup of a satisfactory body of evidence. Furthermore, the United States Food and Drug Administration issued a warning regarding the safety of energy-based technologies for indications such as vaginal “rejuvenation,” cosmetic vaginal treatment, vaginal conditions related to menopause, and symptoms of urinary incontinence and sexual function on July 30, 2018.

February 2020

Assessment and Hormonal Management in Adolescent and Adult Trans People, With Attention for Sexual Function and Satisfaction

There is a general lack of recommendations for and basic information tailored at sexologists and other health-care professionals for when they encounter trans people in their practice.

November 2019

Hormonal Contraception and Female Sexuality

Hormonal contraception is available worldwide in many different forms. Fear of side effects and health concerns are among the main reasons for not using contraceptives or discontinuing their use.

October 2019

Low-Intensity Shock Wave Therapy in Sexual Medicine — Clinical Recommendations from the European Society of Sexual Medicine (ESSM)

Low-intensity shockwave therapy (LISWT) has been investigated for the treatment of uroandrological disorders including erectile dysfunction (ED), Peyronie’s disease (PD) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) with controversial findings.

X